Published in Br J Urol on December 01, 1979
High pressure chronic retention. Br Med J (Clin Res Ed) (1983) 1.70
Pressure flow urodynamic studies: the gold standard for diagnosing bladder outlet obstruction. Rev Urol (2005) 1.49
Bladder outlet obstruction: etiology and evaluation. Rev Urol (2005) 1.03
Variable intrathoracic airways obstruction masquerading as asthma. Br Med J (Clin Res Ed) (1983) 0.89
The anatomy of the prostate: relationship with prostatic infection. Infection (1991) 0.80
Dysfunctional voiding: A review of the terminology, presentation, evaluation and management in children and adults. Indian J Urol (2011) 0.78
High pressure chronic retention. Br Med J (Clin Res Ed) (1983) 1.70
Morphometric evidence for bone resorption and replacement in prostate cancer. Br J Urol (1991) 1.22
Primary prostatic epithelial cell binding to human bone marrow stroma and the role of alpha2beta1 integrin. Clin Exp Metastasis (1997) 1.07
Vesico-intestinal fistulae. Br J Surg (1972) 1.05
Alternative splicing of p53 and p73: the novel p53 splice variant p53delta is an independent prognostic marker in ovarian cancer. Oncogene (2010) 1.02
Interaction of prostate epithelial cells from benign and malignant tumor tissue with bone-marrow stroma. Prostate (1998) 1.01
Interactions of human prostatic epithelial cells with bone marrow endothelium: binding and invasion. Br J Cancer (2001) 1.00
Multicentre survey of urinary tract infections in general practice. Clinical trial of single dose treatment with sulfametopyrazine (Kelfizine-W). Br J Urol (1972) 0.99
Reversible hypertension associated with unrecognised high pressure chronic retention of urine. Lancet (1987) 0.99
Loss of HLA class I expression in prostate cancer: implications for immunotherapy. Urology (1995) 0.97
Osteoblast function and osteomalacia in metastatic prostate cancer. Eur Urol (1993) 0.97
Expression of erbB-3 protein in colorectal adenocarcinoma: correlation with poor survival. J Cancer Res Clin Oncol (2000) 0.94
Renal pelvic pressures in human chronic obstructive uropathy. Br J Urol (1984) 0.93
Factors affecting visual outcome in children following uniocular traumatic cataract. Eye (Lond) (1995) 0.92
Light penetration in bladder tissue: implications for the intravesical photodynamic therapy of bladder tumours. BJU Int (2000) 0.92
Identification of the poor risk patient with "prostatism" and detrusor failure. Br J Urol (1986) 0.92
Paradoxical expression of E-cadherin in prostatic bone metastases. BJU Int (1999) 0.92
Seminal vesicle tumours. J R Soc Med (1978) 0.92
Prostatodynia--physiological characteristics and rational management with muscle relaxants. Br J Urol (1981) 0.91
Neuroendocrine differentiation and prognosis in prostatic adenocarcinoma. Br J Urol (1997) 0.90
Practical management of patients with dilated upper tracts and chronic retention of urine. Br J Urol (1984) 0.90
Disodium pamidronate identifies differential osteoclastic bone resorption in metastatic prostate cancer. Br J Urol (1992) 0.89
Osteoclast inhibition by pamidronate in metastatic prostate cancer: a preliminary study. Br J Cancer (1991) 0.89
Intravascular complications of transurethral resection of the prostate. Br J Urol (1982) 0.88
Growth inhibition of prostate cell lines in vitro by phyto-oestrogens. Br J Urol (1998) 0.87
Prostate disease: management options for the primary healthcare team. Report of a working party of the British Prostate Group. Postgrad Med J (1995) 0.86
Scatter factor influences the formation of prostate epithelial cell colonies on bone marrow stroma in vitro. Clin Exp Metastasis (1999) 0.86
DeltaNp73 stabilises TAp73 proteins but compromises their function due to inhibitory hetero-oligomer formation. Cell Death Differ (2004) 0.85
The management of vesicoureteric reflux in children. Br J Urol (1978) 0.84
The effects of orchidectomy on skeletal metabolism in metastatic prostate cancer. Scand J Urol Nephrol (1993) 0.83
Relationship between bladder morphology and long-term outcome of treatment in patients with high pressure chronic retention of urine. Br J Urol (1991) 0.83
Molecular prediction of progression in patients with conservatively managed prostate cancer. Urology (2001) 0.83
Arterial embolisation in renal carcinoma: a useful procedure? Br J Urol (1982) 0.82
Postoperative urinary tract infections in urology and gynaecology: a review. J R Soc Med (1980) 0.82
Franzen-positive carcinoma of the prostate in histologically benign glands. Cancer Detect Prev (1982) 0.81
Late results in the management of primary pelvic hydronephrosis. Br J Urol (1972) 0.80
Optimization of the reverse transcriptase polymerase chain reaction for the detection of circulating prostate cells. Br J Cancer (2000) 0.80
The long-term results of ileal conduit urinary diversion in children. Br J Urol (1979) 0.80
Management of closed renal injuries. Br J Urol (1971) 0.79
Urinary symptoms following hysterectomy. Br J Urol (1970) 0.79
Increased survival of patients with massive lymphadenopathy and prostate cancer: evidence of heterogeneous tumour behaviour. Br J Urol (1990) 0.79
Assessment of the nephron segments involved in post-obstructive diuresis in man, using lithium clearance. Br J Urol (1989) 0.78
The biphasic nature of renal functional recovery following relief of chronic obstructive uropathy. Br J Urol (1988) 0.77
Conservative management of prostate cancer. Lancet (1988) 0.77
Levels of prostate specific antigen that predict skeletal spread in prostate cancer. Br J Urol (1992) 0.77
Outcome and prognostic factors in patients with advanced prostate cancer and obstructive uropathy. Br J Urol (1992) 0.77
Apoptosis and expression of apoptotic regulators in the human testis following short- and long-term anti-androgen treatment. Mol Hum Reprod (1998) 0.77
Altered saccharide sequences in two groups of patients with metastatic prostatic carcinoma. Br J Urol (1994) 0.77
Localized amyloid of the ureter--case report and review of the literature. Histopathology (1983) 0.76
p185neu is expressed in yolk sac during rat postimplantation development. J Anat (1994) 0.75
Problems in the management of primary pelvic hydronephrosis. Proc R Soc Med (1967) 0.75
Postobstructive renal function. Semin Urol (1987) 0.75
The role of palliative urinary diversion in the management of bladder cancer. Br J Urol (1982) 0.75
The Bristol Pyelonephritis Registry: 10 years on. Br J Urol (1975) 0.75
Disturbance in sodium regulating hormones in chronic obstructive uropathy. Br J Urol (1991) 0.75
Preferential preservation of bone mineralisation by LHRH agonists in the treatment of metastatic prostate cancer. Eur Urol (1991) 0.75
The use of 123I-Hippuran renography in the management of synchronous bilateral upper urinary tract transitional cell carcinomata. Br J Radiol (1992) 0.75
Inhibition of growth of primary human prostate cells by phytoestrogens. J Med Food (1999) 0.75
Ki-67 index in metastatic prostate cancer. Eur Urol (2001) 0.75
Urethrolysis in the management of females with recurrent frequency and dysuria. Br J Urol (1981) 0.75
Chemotherapy of urinary tract infections in children. J Antimicrob Chemother (1977) 0.75
Mechanism of upper tract dilatation in patients with thick walled bladders, chronic retention of urine and associated hydroureteronephrosis. J Urol (1988) 0.75
The late symptomatic and functional results of enterocystoplasty. Br J Urol (1978) 0.75
Sympathetic nervous system and dysfunction of the lower urinary tract. Clin Sci (Lond) (1986) 0.75
The effect of aprotinin on risk of acute renal failure requiring dialysis after on-pump cardiac surgery. Anaesth Intensive Care (2008) 0.75
Compliance studies, pressure flow measurements and renal function assessment in patients with upper urinary tract dilatation. J Urol (1987) 0.75
Clinical blind trial of three drugs in the control of renal colic. Br J Urol (1967) 0.75
Interactive obstructive uropathy in man. Br J Urol (1992) 0.75
Pressure changes in the dilated upper urinary tract on perfusion at varying flow rates. Br J Urol (1985) 0.75
Detrusor activity during micturition in female patients. Prog Clin Biol Res (1981) 0.75
Urinary tract infections in neurogenic bladder. J Antimicrob Chemother (1977) 0.75
A comparison of zidovudine, didanosine, zalcitabine and no antiretroviral therapy in patients with advanced HIV disease. Int J STD AIDS (1995) 0.75
Effect of bladder filling on upper tract urodynamics in man. Br J Urol (1990) 0.75
Effects of bladder pressure on renal function. Lancet (1985) 0.75